« Back to Record
Hanker, A. A., Frampton, G. G., Sanford, E., Owens, P., Becker, J., Groseclose, R. M., Castellino, S., Joensuu, H., Huober, J., Brase, J. C., Majjaj, S., Garrett, J. J., Brohée, S., Venet, D., Brown, D. N., Baselga, J., Piccart-Gebhart, M., Sotiriou, C., Arteaga, C. L., Estrada, M. V., Moore, P. P., Ericsson, P. G., Koch, J. J., Langley, E., Singh, S., & Kim, P. P. (2017). HER2-overexpressing breast cancers amplify FGFR signaling upon acquisition of resistance to dual therapeutic blockade of HER2. Clinical cancer research, 23(15), 4323-4334. doi:10.1158/1078-0432.CCR-16-2287
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/259216



